Kate Gehl is an antitrust and competition lawyer who provides strategic counsel to clients in the areas of antitrust litigation and investigations, including civil and criminal enforcement. With a reputation for practical advice, Kate routinely counsels clients across numerous industries on business matters related to antitrust and competition.
Kate primarily works with companies in the technology, manufacturing, pharmaceuticals, life sciences, and health care sectors. Kate is a seasoned litigator with over a decade of experience handling high-stakes cases. She listens to her clients’ needs and obtains a full understanding of their business, which provides results. Kate’s time as a former federal judicial clerk also makes her uniquely qualified to provide insightful strategic advice on litigation strategy, with an inside perspective.
In addition to her antitrust investigation and litigation practice, Kate regularly provides antitrust guidance related to intellectual property licensing, including licensing practices related to standard essential patents and patent pools, participation in trade associations, industry organizations and standard setting organizations, product distribution and supply chain logistics, e-commerce, joint ventures and commercial agreements, collaborations with competitors, and general antitrust compliance. Kate has particular experience litigating antitrust issues that arise in the context of patent infringement litigation or other disputes involving intellectual property.
Parallel to her antitrust litigation practice, Kate maintains a practice representing businesses in complex commercial litigation. She has significant experience in complex electronic discovery and has worked with experts to develop reports and testimony, and she has written briefs and motions at all stages of litigation in federal and state courts across the country.
More Legal and Business Bylines From Kate E. Gehl
- Biden’s Executive Order on Competition Could Spell Changes for the Pharmaceutical Industry - (Posted On Tuesday, July 20, 2021)
- Illinois Appellate Court Recognizes Common Interest Exception to Waiver of Privilege Rule - (Posted On Wednesday, December 13, 2017)
- FTC Advisory Opinion Says Hospital’s Proposed Prescription Program for Affiliated Entity Employees is Exempt from Robinson-Patman Act Price Discrimination Restrictions - (Posted On Wednesday, November 15, 2017)
- Student-Athletes Seek $45M in Legal Fees and Costs in NCAA Scholarship Antitrust Lawsuit - (Posted On Monday, September 11, 2017)
- DOJ and FTC Issue Updated Antitrust Guidelines on Licensing of Intellectual Property - (Posted On Thursday, March 02, 2017)
- Spokeo and "No-Injury" Class Actions in Wisconsin Courts - (Posted On Monday, October 03, 2016)
- Update: Antitrust-Intellectual Property Licensing Guidelines - (Posted On Monday, September 19, 2016)
- DOJ and FTC Update Antitrust-Intellectual Property Licensing Guidelines - (Posted On Friday, September 09, 2016)
- Seventh Circuit Reverses Package Size Promotional Service Decision Under Robinson-Patman Act - (Posted On Wednesday, August 17, 2016)
- Seventh Circuit Limits Construction Lender’s Use of Title Insurance Policy to Cover Construction Liens Created by Lender’s Cutoff of Funding - (Posted On Wednesday, July 01, 2015)